Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)

NCT00290407 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped terminated due to lack of accrual

Conditions

Leukemia, Lymphocytic, Chronic
Lymphoma, Small Lymphocytic

Interventions

DRUG: Rituximab
DIETARY_SUPPLEMENT: Beta-Glucan

Sponsor

University of Louisville

Collaborators

[object Object]